Tag: AI

July 25, 2024

The use of artificial intelligence (AI) is seeing a surge in a variety of industries. But does the regulated nature of bio/pharmaceutical development, manufacturing, and commercialization serve up unique challenges for incorporating AI into processes? According to Siegfried Schmitt, vice-president, […]

July 18, 2024

The new project will focus on the real-world use of Brainomix’s artificial intelligence-powered Brainomix 360 e-Lung software, which was recently approved by the FDA in May to assist in the diagnosis and assessment of patients with interstitial lung diseases (ILDs) from medical […]

January 16, 2024

Their novel approach to high-throughput experimentation (HTE) could do away with the current need to run trial-and-error experiments to see how chemicals used to make medicines react with one another, predicting their behaviour virtually, and has been described in a […]

September 29, 2023

This survey conducted by the authors examined factors of Roger’s diffusion of innovation theory related to adopting machine learning (ML) and artificial intelligence (AI) in the bio/pharmaceutical manufacturing industry. The sample included industry leaders and bio/pharmaceutical professionals with experience in […]

August 11, 2023

On Aug. 4, 2023, FDA released a guidance document, Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs). The guidance gives both applicants and manufacturers of drugs recommendations for estimating the mutagenic and carcinogenic potential of NDSRIs that could […]

July 3, 2023

Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology. The study by researchers at New York University, Columbia Engineering, and the New York Genome […]

January 24, 2023

The partnership between Sanofi and CytoReason – for an undisclosed, multimillion dollar amount – forms part of an ongoing collaboration begun in 2021, which originally focused on obtaining advanced mechanistic insights for asthma endotypes. The collaboration takes CytoReason’s partnering with […]

January 5, 2023

For biotech to achieve our societal goals, we need to build up the foundational systems that support modern science. Government investment will be critical. Technological resources will also be instrumental — from overcoming current technical skills gaps to modernising how […]

December 2, 2022

Using data-informed insights derived by effectively implemented datasets, artificial intelligence/machine learning capabilities, and technology sponsors can realise increased predictability in their study planning from protocol design through enrolment strategy. Critical analysis in protocol design Nearly eight out of 10 (78%) […]

November 25, 2022

Gene therapy is a medical field that focuses on developing personalized treatments that have the potential to save or change lives by inactivating a defective gene or replacing it with a functional one. As AI has already proven its ability […]

November 9, 2022

The alliance is backloaded, with $21.5 million paid upfront and Insilico also in line for mid-single to up to low double-digit tiered royalties for any products developed, but it is comfortably the Chinese company’s largest deal to date. “This collaboration […]

August 25, 2022

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. […]

March 28, 2022

Researchers at the New York Stem Cell Foundation Research Institute have unveiled a new platform for discovering cellular signatures of disease, which integrates robotic systems for studying patient cells with artificial intelligence methods for image analysis. Using their automated cell […]

January 7, 2022

Merck is taking a deep dive into complex proteins with the help of artificial-intelligence-powered drug discovery company Absci. The two companies have signed a research collaboration for up to three targets in a deal worth up to $610 million in […]

May 13, 2021

The new molecule – called DSP-0038 – is being developed by Japan’s Sumitomo Dainippon Pharma (DSP), which is now starting a phase 1 trial in the US as a treatment for psychosis associated with Alzheimer’s, and to see if it […]

October 7, 2020

A team of electrical engineers, computer scientists, and biomedical engineers at the University of California-Irvine report that they have created a new lab-on-a-chip that can help study tumor heterogeneity to reduce resistance to cancer therapies. In a paper “A Machine […]

August 25, 2020

Artificial intelligence (AI) has huge potential in bioprocessing. Its ability to model process data in real-time and feed this information into automated control systems is attractive to efficiency-focused drug companies. According to a recent report, biopharma companies are warming to […]

August 5, 2020

All too often, artificial intelligence (AI) and machine learning get demonized in pop culture as being the harbinger of human armageddon. However, when we separate fact from science fiction, we find that AI is a powerful tool that can be […]

February 26, 2020

If a company strives for innovation, there’s no room for lagging behind with their software. Similarly to AI and machine learning, the internet of things (IoT) provides the pharmaceutical industry with a selection of new opportunities, including; better control of […]